BIOMAT Database Logo BIOMAT Database Logo

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. 1997

D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Sanofi Recherche, Toulouse, France.

SR 142948A, 2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylc arbamoyl)-2-isopropylphenyl)-1H-pyrazole3-carbonyl]amino] adamantane-2-carboxylic acid, hydrochloride, a new and extremely potent neurotensin (NT) receptor antagonist, has been characterized in comparison with SR 48692. This selective compound possesses nanomolar affinities for NT receptors, recognizes the two binding sites described for the NT receptor and fully displaces [3H]SR 48692 specific binding. SR 142948A antagonizes the classical in vitro NT effects, i.e., inositol monophosphate formation in HT 29 cells (IC50 = 3.9 nM) or intracellular calcium mobilization in Chinese hamster ovary cells transfected with the human receptor. It dose-dependently (0.04-640 x 10(-3) mg/kg p.o.) inhibits the turning behavior induced by unilateral intrastriatal injection of NT in mice, with the biphasic profile previously seen for SR 48692. At 0.1 mg/kg (i.p.), it completely antagonizes NT-evoked acetylcholine release in the rat striatum. In contrast to SR 48692, SR 142948A (p.o.) blocks both hypothermia and analgesia induced by i.c.v. injection of NT (mice and/or rats) but is unable to modify the dopamine release evoked by NT injection into the ventral tegmental area. In summary, SR 142948A retains the properties of the lead compound SR 48692 (no intrinsic agonist activity, oral bioavailability, long duration of action and good brain access), reveals a wider spectrum of activity than SR 48692 (probably due to the inhibition of NT receptor subtypes) and represents an additional tool for further exploration of the therapeutic potential of this class of compounds.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007295 Inositol Phosphates Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID. Inositol Phosphate,Phosphate, Inositol,Phosphates, Inositol
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009496 Neurotensin A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon

Related Publications

D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist.
October 1997, Neuropeptides,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
October 1991, The Journal of pharmacology and experimental therapeutics,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
August 1992, The Journal of pharmacology and experimental therapeutics,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
June 2001, Journal of neurochemistry,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
January 1993, Proceedings of the National Academy of Sciences of the United States of America,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
May 2002, Canadian journal of physiology and pharmacology,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
December 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice.
June 2008, Neuropharmacology,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
June 2002, Naunyn-Schmiedeberg's archives of pharmacology,
D Gully, and B Labeeuw, and R Boigegrain, and F Oury-Donat, and A Bachy, and M Poncelet, and R Steinberg, and M F Suaud-Chagny, and V Santucci, and N Vita, and F Pecceu, and C Labbé-Jullié, and P Kitabgi, and P Soubrié, and G Le Fur, and J P Maffrand
Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
February 1992, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!